{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:35:29Z","timestamp":1791326129774,"version":"4.3.1"},"reference-count":58,"publisher":"American Society of Hematology","issue":"12","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2002,6,15]]},"abstract":"<jats:p>The B-cell lymphoproliferative malignancies B-cell chronic lymphocytic leukemia (B-CLL) and mantle cell lymphoma (MCL) share characteristics, including overlapping chromosomal aberrations with deletions on chromosome bands 13q14, 11q23, 17p13, and 6q21 and gains on chromosome bands 3q26, 12q13, and 8q24. To elucidate the biochemical processes involved in the pathogenesis of B-CLL and MCL, we analyzed the expression level of a set of genes that play central roles in apoptotic or cell proliferation pathways and of candidate genes from frequently altered genomic regions, namely ATM, BAX, BCL2, CCND1, CCND3, CDK2,CDK4, CDKN1A, CDKN1B,E2F1, ETV5, MYC, RB1,SELL, TFDP2, TNFSF10, andTP53. Performing real-time quantitative reverse transcription polymerase chain reaction in a panel of patients with MCL and B-CLL and control samples, significant overexpression and underexpression was observed for most of these genes. Statistical analysis of the expression data revealed the combination of CCND1 and CDK4 as the best classifier concerning separation of both lymphoma types. Overexpression in these malignancies suggests ETV5 as a new candidate for a pathogenic factor in B-cell lymphomas. Characteristic deregulation of multiple genes analyzed in this study could be combined in a comprehensive picture of 2 distinctive pathomechanisms in B-CLL and MCL. In B-CLL, the expression parameters are in strong favor of protection of the malignant cells from apoptosis but did not provide evidence for promoting cell cycle. In contrast, in MCL the impairment of apoptosis induction seems to play a minor role, whereas most expression data indicate an enhancement of cell proliferation.<\/jats:p>","DOI":"10.1182\/blood.v99.12.4554","type":"journal-article","created":{"date-parts":[[2002,10,1]],"date-time":"2002-10-01T21:48:18Z","timestamp":1033508898000},"page":"4554-4561","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":108,"title":["Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes"],"prefix":"10.1182","volume":"99","author":[{"given":"Christian","family":"Korz","sequence":"first","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Pscherer","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Benner","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Mertens","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schaffner","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Leupolt","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Do\u0308hner","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lichter","sequence":"additional","affiliation":[{"name":"From Abteilung Molekulare Genetik and Zentrale Einheit Biostatistik, Deutsches Krebsforschungszentrum, Heidelberg, and Abteilung Innere Medizin III, Universita\u0308t Ulm, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222542649900_B1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001090050350","article-title":"Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis.","volume":"77","author":"Do\u0308hner","year":"1999","journal-title":"J Mol Med."},{"key":"2020021222542649900_B2","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.1999.17.1.399","article-title":"B-cell chronic lymphocytic leukemia: a bird of a different feather.","volume":"17","author":"Caligaris-Cappio","year":"1999","journal-title":"J Clin Oncol."},{"key":"2020021222542649900_B3","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1182\/blood.V91.9.3379","article-title":"Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with in vitro and in vivo chemoresponses.","volume":"91","author":"Kitada","year":"1998","journal-title":"Blood."},{"key":"2020021222542649900_B4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/eji.1830230320","article-title":"APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression.","volume":"23","author":"Mapara","year":"1993","journal-title":"Eur J Immunol."},{"key":"2020021222542649900_B5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0145-2126(98)00158-1","article-title":"Qualitative and quantitative characterization of Fas (APO-1\/CD95) on leukemic cells derived from patients with B-cell neoplasms.","volume":"23","author":"Tsuruda","year":"1999","journal-title":"Leuk Res."},{"key":"2020021222542649900_B6","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia.","volume":"333","author":"Rozman","year":"1995","journal-title":"N Engl J Med."},{"key":"2020021222542649900_B7","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1182\/blood.V87.11.4483.bloodjournal87114483","article-title":"Mantle cell lymphoma\u2014an entity comes of age.","volume":"87","author":"Weisenburger","year":"1996","journal-title":"Blood."},{"key":"2020021222542649900_B8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2141.1991.tb08582.x","article-title":"Non-Hodgkin's lymphomas with t(11;14)(q13;q32): a subset of mantle zone\/intermediate lymphocytic lymphoma?","volume":"77","author":"Leroux","year":"1991","journal-title":"Br J Haematol."},{"key":"2020021222542649900_B9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2141.1992.tb08209.x","article-title":"Chromosome 11q rearrangements in B non Hodgkin's lymphoma.","volume":"81","author":"Vandenberghe","year":"1992","journal-title":"Br J Haematol."},{"key":"2020021222542649900_B10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.0.CO;2-M","article-title":"t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia.","volume":"27","author":"Bentz","year":"2000","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021222542649900_B11","first-page":"4365","article-title":"Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants.","volume":"93","author":"Bea","year":"1999","journal-title":"Blood."},{"key":"2020021222542649900_B12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia.","volume":"343","author":"Do\u0308hner","year":"2000","journal-title":"N Engl J Med."},{"key":"2020021222542649900_B13","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U","article-title":"Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma.","volume":"21","author":"Monni","year":"1998","journal-title":"Genes Chromosomes Cancer."},{"key":"2020021222542649900_B14","first-page":"335","article-title":"High-level DNA amplifications are common genetic aberrations in B-cell neoplasms.","volume":"151","author":"Werner","year":"1997","journal-title":"Am J Pathol."},{"key":"2020021222542649900_B15","first-page":"468a","article-title":"Molecular cytogenetic characterization of mantle cell lymphoma [abstract].","volume":"96","author":"Leupolt","year":"2000","journal-title":"Blood."},{"key":"2020021222542649900_B16","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351","article-title":"p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas.","volume":"87","author":"Hernandez","year":"1996","journal-title":"Blood."},{"key":"2020021222542649900_B17","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1182\/blood.V82.11.3452.3452","article-title":"p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1\/MDR3 gene expression.","volume":"82","author":"el Rouby","year":"1993","journal-title":"Blood."},{"key":"2020021222542649900_B18","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1086\/301706","article-title":"ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer.","volume":"62","author":"Stankovic","year":"1998","journal-title":"Am J Hum Genet."},{"key":"2020021222542649900_B19","first-page":"24","article-title":"ATM mutations in B-cell chronic lymphocytic leukemia.","volume":"59","author":"Bullrich","year":"1999","journal-title":"Cancer Res."},{"key":"2020021222542649900_B20","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1182\/blood.V94.2.748","article-title":"Somatic ATM mutations indicate a pathogenic role of ATM in B-cell chronic lymphocytic leukemia.","volume":"94","author":"Schaffner","year":"1999","journal-title":"Blood."},{"key":"2020021222542649900_B21","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1073\/pnas.050400997","article-title":"Mantle cell lymphoma is characterized by inactivation of the ATM gene.","volume":"97","author":"Schaffner","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021222542649900_B22","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood.V84.8.2726.2726","article-title":"PRAD-1\/cyclin D1 gene overexpression in chronic lymphoproliferative disorders: a highly specific marker of mantle cell lymphoma.","volume":"84","author":"Bosch","year":"1994","journal-title":"Blood."},{"key":"2020021222542649900_B23","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/clinchem\/47.2.195","article-title":"Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma.","volume":"47","author":"Bijwaard","year":"2001","journal-title":"Clin Chem."},{"key":"2020021222542649900_B24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1038\/sj.leu.2401599","article-title":"c-myc mRNA expression and genomic alterations in mantle cell lymphomas and other nodal non-Hodgkin's lymphomas.","volume":"13","author":"Hernandez","year":"1999","journal-title":"Leukemia."},{"key":"2020021222542649900_B25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1046\/j.1365-2141.1997.4963301.x","article-title":"Quantitative characterization and potential function of membrane Fas\/APO-1 (CD95) receptors on leukaemic cells from chronic B and T lymphoid leukaemias.","volume":"99","author":"Kamihira","year":"1997","journal-title":"Br J Haematol."},{"key":"2020021222542649900_B26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1002\/(SICI)1097-0215(19960422)69:2<114::AID-IJC8>3.0.CO;2-3","article-title":"Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression.","volume":"69","author":"Agular-Santelises","year":"1996","journal-title":"Int J Cancer."},{"key":"2020021222542649900_B27","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","article-title":"Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional region specific TaqMan probes.","volume":"12","author":"Pongers-Willemse","year":"1998","journal-title":"Leukemia."},{"key":"2020021222542649900_B28","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood.V89.7.2516","article-title":"11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis.","volume":"89","author":"Do\u0308hner","year":"1997","journal-title":"Blood."},{"key":"2020021222542649900_B29","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0145-2126(90)90167-8","article-title":"Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line: evidence of leukemic origin by immunoglobulin gene rearrangement.","volume":"14","author":"Saltman","year":"1990","journal-title":"Leuk Res."},{"key":"2020021222542649900_B30","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2307\/2529881","article-title":"Maximally selected chi square statistics.","volume":"38","author":"Miller","year":"1982","journal-title":"Biometrics."},{"key":"2020021222542649900_B31","volume-title":"Classification and Regression Trees.","author":"Breiman","year":"1984"},{"key":"2020021222542649900_B32","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/35000501","article-title":"Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.","volume":"403","author":"Alizadeh","year":"2000","journal-title":"Nature."},{"key":"2020021222542649900_B33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1002\/1097-0215(200002)9999:9999<::AID-IJC1078>3.0.CO;2-C","article-title":"cDNA microarray gene expression analysis of B-cell chronic lymphocytic leukemia proposes potential new prognostic markers involved in lymphocyte trafficking.","volume":"91","author":"Stratowa","year":"2001","journal-title":"Int J Cancer."},{"key":"2020021222542649900_B34","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1101\/gad.13.12.1501","article-title":"CDK inhibitors: positive and negative regulators of G1-phase progression.","volume":"13","author":"Sherr","year":"1999","journal-title":"Genes Dev."},{"key":"2020021222542649900_B35","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network.","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature."},{"key":"2020021222542649900_B36","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/85798","article-title":"DNA double-strand breaks: signaling, repair and the cancer connection.","volume":"27","author":"Khanna","year":"2001","journal-title":"Nat Genet."},{"key":"2020021222542649900_B37","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1182\/blood.V79.11.2981.2981","article-title":"Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells.","volume":"79","author":"Schena","year":"1992","journal-title":"Blood."},{"key":"2020021222542649900_B38","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1182\/blood.V82.6.1820.1820","article-title":"bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.","volume":"82","author":"Hanada","year":"1993","journal-title":"Blood."},{"key":"2020021222542649900_B39","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/0092-8674(93)90509-O","article-title":"Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death.","volume":"74","author":"Oltvai","year":"1993","journal-title":"Cell."},{"key":"2020021222542649900_B40","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/1074-7613(95)90057-8","article-title":"Identification and characterization of a new member of the TNF family that induces apoptosis.","volume":"3","author":"Wiley","year":"1995","journal-title":"Immunity."},{"key":"2020021222542649900_B41","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1006\/excr.2000.4840","article-title":"The CD95 (APO-1\/Fas) and the TRAIL (APO-2L) apoptosis systems.","volume":"256","author":"Walczak","year":"2000","journal-title":"Exp Cell Res."},{"key":"2020021222542649900_B42","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/0092-8674(93)90636-5","article-title":"Mammalian G1 cyclins.","volume":"73","author":"Sherr","year":"1993","journal-title":"Cell."},{"key":"2020021222542649900_B43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.1997.3776","article-title":"The retinoblastoma protein pathway in cell cycle control and cancer.","volume":"237","author":"Bartek","year":"1997","journal-title":"Exp Cell Res."},{"key":"2020021222542649900_B44","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1200\/JCO.1993.11.4.802","article-title":"Intermediate lymphocytic lymphoma: clinical and pathologic features of a recently characterized subtype of non-Hodgkin's lymphoma.","volume":"11","author":"Shivdasani","year":"1993","journal-title":"J Clin Oncol."},{"key":"2020021222542649900_B45","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1182\/blood.V95.2.619","article-title":"Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma.","volume":"95","author":"Chiarle","year":"2000","journal-title":"Blood."},{"key":"2020021222542649900_B46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0968-0004(00)89005-2","article-title":"D-type cyclins.","volume":"20","author":"Sherr","year":"1995","journal-title":"Trends Biochem Sci."},{"key":"2020021222542649900_B47","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1182\/blood.V90.8.3154","article-title":"Cyclin D1 expression in mantle cell lymphoma is accompanied by down-regulation of cyclin D3 and is not related to the proliferative activity.","volume":"90","author":"Ott","year":"1997","journal-title":"Blood."},{"key":"2020021222542649900_B48","doi-asserted-by":"crossref","first-page":"20412","DOI":"10.1016\/S0021-9258(19)88717-3","article-title":"Cloning and characterization of human cyclin D3, a cDNA closely related in sequence to the PRAD1\/cyclin D1 proto-oncogene.","volume":"267","author":"Motokura","year":"1992","journal-title":"J Biol Chem."},{"key":"2020021222542649900_B49","first-page":"4608","article-title":"Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma.","volume":"57","author":"Dreyling","year":"1997","journal-title":"Cancer Res."},{"key":"2020021222542649900_B50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1182\/blood.V89.1.272","article-title":"Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas.","volume":"89","author":"Pinyol","year":"1997","journal-title":"Blood."},{"key":"2020021222542649900_B51","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1182\/blood.V86.7.2724.2724","article-title":"Mutational analysis of the CDKN2 (MTS1\/p16ink4A) gene in primary B-cell lymphomas.","volume":"86","author":"Uchida","year":"1995","journal-title":"Blood."},{"key":"2020021222542649900_B52","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/S0955-0674(00)00151-4","article-title":"Regulation of G(1) cyclin-dependent kinases in the mammalian cell cycle.","volume":"12","author":"Ekholm","year":"2000","journal-title":"Curr Opin Cell Biol."},{"key":"2020021222542649900_B53","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0014-5793(01)02114-7","article-title":"Pathways governing G1\/S transition and their response to DNA damage.","volume":"490","author":"Bartek","year":"2001","journal-title":"FEBS Lett."},{"key":"2020021222542649900_B54","doi-asserted-by":"crossref","first-page":"12009","DOI":"10.1074\/jbc.274.17.12009","article-title":"Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes.","volume":"274","author":"van der Sman","year":"1999","journal-title":"J Biol Chem."},{"key":"2020021222542649900_B55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0962-8924(98)01251-3","article-title":"Control of cell proliferation by Myc.","volume":"8","author":"Bouchard","year":"1998","journal-title":"Trends Cell Biol."},{"key":"2020021222542649900_B56","first-page":"1745","article-title":"The ETS-related transcription factor ERM is a nuclear target of signaling cascades involving MAPK and PKA.","volume":"13","author":"Janknecht","year":"1996","journal-title":"Oncogene."},{"key":"2020021222542649900_B57","doi-asserted-by":"crossref","first-page":"23795","DOI":"10.1074\/jbc.270.40.23795","article-title":"ERM, a PEA3 subfamily of Ets transcription factors, can cooperate with c-Jun.","volume":"270","author":"Nakae","year":"1995","journal-title":"J Biol Chem."},{"key":"2020021222542649900_B58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/0-306-46832-8_13","article-title":"The PEA3 group of ETS-related transcription factors: role in breast cancer metastasis.","volume":"480","author":"de Launoit","year":"2000","journal-title":"Adv Exp Med Biol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/12\/4554\/1685882\/h81202004554.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/99\/12\/4554\/1685882\/h81202004554.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T12:35:02Z","timestamp":1622205302000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/99\/12\/4554\/105960\/Evidence-for-distinct-pathomechanisms-in-Bcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,6,15]]},"references-count":58,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2002,6,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v99.12.4554","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2002,6,15]]}}}